D-0276-2022 Class II Terminated
FDA drug recall D-0276-2022 was initiated by Ascent Pharmaceuticals, Inc. on Nov 19, 2021 and is designated Class II. Reason for recall: Product Mix-up The recall status is terminated (terminated Dec 6, 2023). Affected quantity: 9744 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 15, 2021
- Initiation Date
- Nov 19, 2021
- Termination Date
- Dec 6, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 9744 bottles
Product description
Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325 mg, 100-count bottle, Rx only, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, Manufactured by: Ascent Pharmaceuticals, Inc., Central Islip, NY 11722, NDC 31722-997-01.
Reason for recall
Product Mix-up
Distribution pattern
USA Nationwide
Code information
Lot #: 21070817, Exp 6/2023
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0276-2022
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026